Summary by Moomoo AI
DONG SUNSHINE CHANGJIANG PHARMACEUTICALS (HEC CJ PHARM) ANNOUNCED ON 14 MARCH 2024 THAT DURING ITS PRIVATISATION TRANSACTION, EXECUTIVES RECEIVED TRANSACTION DISCLOSURES PURSUANT TO RULE 22 OF THE HONG KONG CODE ON ACQUISITIONS AND MERGERS. The disclosure relates to CICC Financial Trading Limited's liquidation on March 13, 2024 of a derivative contract for Dongsun Changjiang Pharmaceutical, involving a quantity of 620,000 units, which will expire on March 15, 2025. The total amount of the transaction was $6,689,424.91 and $6,691,689.35, respectively, with a post-trade holding of 1,344,200 units. CICC Financial Trading Limited is an exempt self-dealing seller associated with the Contracting Party and the transaction is conducted for its own account.